Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday’s session after the company reported worse-than-expected FY24 financial results…
XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.